About Technology Issues FAQ

Links

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.